Cerebral Tumefactive Inflammatory Lesion Occurrence During Ixekizumab Treatment in a Patient With Active Psoriatic Arthritis.

Antonio MarangiFrancesco BenvenutiLinda MazzaiGiulio RivaDiana PoloIlaria FranceschettiPierino De SandreMariano Agostino ZanussoGiovanni ScanelliFrancesco Perini

Published in: The neurologist (2024)

This is the first case of a cerebral inflammatory lesion occurring during treatment with ixekizumab. Although very rare, neurological complications may occur during anti-IL-17A therapies, thus leading to the need for careful monitoring of patients exposed to these drugs.

Keyphrases

end stage renal disease
ejection fraction
oxidative stress
newly diagnosed
chronic kidney disease
risk assessment
peritoneal dialysis
risk factors
blood brain barrier
patient reported